Various PPAR-γ agonists like pioglitazone have been shown to reduce myocardial injury (infarct size) and inflammation caused by regional myocardial ischemia and reperfusion in rats and rabbits [15]. This evidence concerns the gene PPARG and myocardial ischemia.